Guided by the spirit of the 20th National Congress of the Communist Party of China, innovation and integration in medical technology have become a significant force driving the construction of the Healthy China strategy. From October 10th to 12th, the 2025 Beijing-Tianjin-Hebei Cerebrovascular Disease Prevention and Treatment Academic Alliance · The Second Xiong'an Cerebrovascular Disease Prevention and Treatment Conference, as well as the Academic Conference of the National Health Commission's Advanced Cognitive Disorder Diagnosis and Treatment Construction Center, was grandly held in Shijiazhuang, Hebei. As a leading enterprise in the field of brain disease rehabilitation, Dukang Medical made a significant appearance with its series of non-invasive brain nerve regulation technology products, leveraging technological innovation to facilitate a new paradigm in cerebrovascular disease prevention and treatment.

The report of the 20th National Congress of the Communist Party of China clearly stated: "We will promote the construction of a healthy China and place the protection of people's health in a strategic position of priority development." At the same time, national policies such as the "Healthy China 2030" Planning Outline, the "14th Five-Year Plan for National Health Informatization," and the "Beijing-Tianjin-Hebei Coordinated Development Planning Outline" have pointed out the direction for integrated and collaborative innovation in the medical industry. Dukang Medical closely follows the national pace and always regards "driving the upgrading of the rehabilitation industry through technological innovation" as its core mission. Participating in this conference is not only an important action for Dukang Medical to respond to the national call and contribute to the construction of the cerebrovascular disease prevention and control system, but also an important window to showcase the cutting-edge achievements of non-invasive brain nerve regulation technology in the field of neurological rehabilitation and brain function remodeling.

Dukang Medical showcased a series of non-invasive brain nerve regulation technology equipment, including repetitive transcranial magnetic stimulator, transcranial direct current stimulator, transcranial ultrasound electrotherapy device, transcranial magnetic brain reflex electrotherapy device, and electroencephalography therapy device. This series of equipment, due to its advantages of safety, non-invasiveness, convenient operation, and few adverse reactions, provides new ideas for the treatment of neurological related diseases, psychiatric related diseases, ischemic cerebrovascular diseases, childhood developmental related diseases, and cranial brain injury related diseases, demonstrating great potential.

These innovative achievements not only reflect the depth of Dukan's technology in the field of neural regulation, but also represent the strength of China's independent innovation in medical equipment. Several participating experts and professors highly recognized the clinical performance of Dukan's products in the rehabilitation of cognitive impairment and brain dysfunction after stroke, and fully affirmed Dukan's exploratory spirit in technological innovation and clinical integration. As an important undertaking area for the coordinated development strategy of Beijing-Tianjin-Hebei, Shijiazhuang is accelerating the formation of a new highland for the agglomeration of the biomedical and medical device industries. As a representative of the city's gazelle enterprises, Dukan Medical will continue to actively promote the coordinated development of regional industrial chains, innovation chains, and service chains. Adhering to the brand vision of "focusing on brain disease rehabilitation and contributing to a healthy China", it will continue to deepen the scientific research transformation and clinical application of non-invasive brain nerve regulation technology. With more forward-looking innovative achievements, it will help implement the strategy of a healthy China and contribute Dukan's strength to building a high-quality cerebrovascular disease prevention, treatment, and rehabilitation system.